Surgical Tumor Ablation Market Size, Share, And Growth Report 2032

Surgical Tumor Ablation Market Size

The global surgical tumor ablation market size was worth around USD 2.11 billion in 2023 and is predicted to grow to around USD 6.44 billion by 2032 with a compound annual growth rate (CAGR) of roughly 13.2% between 2024 and 2032.

The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD billion). The report covers a forecast and an analysis of the surgical tumor ablation market on a global and regional level.

Request Free Sample

Surgical Tumor Ablation Market: Overview

Tumor ablation is referred to as a minimally-invasive technique for the treatment or destruction of cancer cells. Certain probes like needles are used to freeze or burn cancerous cells without conventional surgical treatment. The imaging techniques like MRI), ultrasound, or CT scans are used to direct, position, and guide the needle probe to the tumor. When the probe is within the cancerous cell through a tiny hole, it gets bind to a generator that burns or freezes cancer.

Increasing prevalence of cancer across the globe is creating the demand for an efficient and effective treatment that can improve patient health at a relatively lower time, with minimal invasion and pain and at affordable costs. This is the primary growth driver of the global surgical tumor ablation market. Other prominent factors boosting the surgical tumor ablation market growth are the rising awareness about the advantages of tumor ablation over conventional treatment methods and growing investments made in tumor ablation techniques worldwide. Furthermore, technological advancements related to the thermal ablation technique are also expected to fuel the surgical tumor ablation market growth in the upcoming years. However, the change in government reforms may hinder the global surgical tumor ablation market growth in the years ahead.

Request Free Sample

Surgical Tumor Ablation Market: Segmentation

The study provides a decisive view of the surgical tumor ablation market by segmenting it based on technology, application, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.

Based on technology, the market includes cryoablation, microwave ablation, radiofrequency ablation, and others.

By technology, the microwave ablation segment is expected to register the highest growth rate in the future, due to product related technological advancements and benefits like consistency in high temperature, lower procedural pain, larger tumor ablation volume, and optimal heating of the cystic mass.

By application, the global surgical tumor ablation market is categorized into lung cancer, prostate cancer, breast cancer, liver cancer, and others. The liver cancer segment is estimated to hold a notable market share in 2023, whereas the lung cancer segment is expected to show a high CAGR over the forecast time period.

Surgical Tumor Ablation Market: Report Scope

Surgical Tumor Ablation Market: Regional Analysis

The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

The North American surgical tumor ablation market is anticipated to continue its regional dominance over the forecast timeframe as well. This can be attributed to Well-planned and implemented healthcare reforms, high adoption of advance therapeutic procedure, increasing prevalence of cancer, and high purchasing power of the regional population. Europe held the second spot in the global surgical tumor ablation market followed by the Asia Pacific. The Asia Pacific surgical tumor ablation market is proposed to register the highest growth rate over the projected timeframe, owing to the increasing cancer prevalence, rising disposable income of the regional population, and growing number of government initiative with favorable reimbursement policies.

Surgical Tumor Ablation Market: Competitive Players

Some key players in the global surgical tumor ablation market are:

• Galil Medical
• Misonix
• HealthTronics
• AngioDynamics
• Covidien
• Boston Scientific Corporation
• Medtronic
• SonaCare Medical
• EDAP TMS
• NeuWave Medical

The Global Surgical Tumor Ablation Market is segmented as follows:

Global Surgical Tumor Ablation Market: Technology Analysis

• Radiofrequency Ablation
• Microwave Ablation
• Cryoablation
• Others

Global Surgical Tumor Ablation Market: Application Analysis

• Liver Cancer
• Breast Cancer
• Lung Cancer
• Prostate Cancer
• Others

Global Surgical Tumor Ablation Market: Regional Analysis

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• The Middle East and Africa